Who
Elizabeth Bhatt
President and COO
Company insider
Files Form 4 as: President and COO, Septerna; Director, eFFECTOR Therapeutics; Chief Bus. & Strategy Officer, Applied Molecular Transport; Chief Operating Officer, Achaogen.
In numbers
- Trades disclosed
- 68
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $3.7M
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 11 Sep 2018
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $27K4,000 at $6.81 | filing |
| 15 Oct 2026filed 19 Oct 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $40K1,094 at $36.87 | filing |
| 15 Oct 2026filed 19 Oct 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $109K2,906 at $37.61 | filing |
| 15 Oct 2026filed 19 Oct 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $127K18,681 at $6.81 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $17K6,319 at $2.76 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $1.1M25,000 at $44.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,681 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,319 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,681 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,319 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $127K18,681 at $6.81 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $17K6,319 at $2.76 | filing |
| 11 Aug 2026filed 13 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $1.1M25,000 at $44.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $27K4,000 at $6.81 | filing |
| 15 Jul 2026filed 17 Jul 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $136K4,000 at $33.99 | filing |
| 15 Jul 2026filed 17 Jul 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $27K4,000 at $6.81 | filing |
| 15 Jul 2026filed 17 Jul 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $136K4,000 at $33.99 | filing |
News
Comparing Septerna (NASDAQ:SEPN) and INmune Bio (NASDAQ:INMB)SEPN · themarketsdaily.com · 24 Oct 2026Septerna (NASDAQ:SEPN) COO Sells $149,640.00 in StockSEPN · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Elizabeth Bhatt; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.